ARTICLES BY THIS AUTHOR

• 4/29/2020

  First oral GLP-1 receptor agonist for type 2 diabetes reaches Canadian market

  Novo Nordisk introduces Rybelsus, an oral formulation of semaglutide
• 4/29/2020

  Potential benefits of tax loss selling

• 4/29/2020

  Anticipating N95 mask shortage, hospital turns to full face snorkel masks

  Results are promising for masks with a filter added to catch hazardous particles
• 4/29/2020

  How medical experts decide which treatments should be used for COVID-19

  Ontario has formed two special committees to sift through emerging research on how best to treat he new disease
• 4/29/2020

  Ontario and B.C. data find drop in people seeking care for serious heart attacks

• 4/29/2020

  ICU continues to deal with cases during COVID-19 pandemic with operating changes

• 4/29/2020

  Doctors fret over surgery backlog after immediate COVID 19 crisis

• 4/28/2020

  New guideline on treating severe and non-severe COVID-19: CMAJ

• 4/28/2020

  Why we need income stabilization benefits for MDs

• 4/28/2020

  Stuart Lake Hospital redevelopment project reaches RFQ stage